Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group

Completed · Phase 2

Conditions studied: Major Depressive Disorder, Major Depression, Unipolar Depression

In brief

Our goal is to study pharmacogenetics in Mexican-Americans, using depression treatments as a proof of the concept that pharmacogenetic approaches can be used to optimize treatment strategies for common and complex disorders in this population.

Key facts

Study ID

NCT00265291

Run by

National Institute of General Medical Sciences (NIGMS)

People needed

700

Starts

1999-11-01

Expected to finish

2008-10-01

Last updated by the study team

2008-10-10

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.

Where it is running

• Center for Pharmacogenomics, University of Miami — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.